CASTAGNA, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 8.372
EU - Europa 6.374
AS - Asia 4.531
SA - Sud America 645
Continente sconosciuto - Info sul continente non disponibili 166
AF - Africa 144
OC - Oceania 14
Totale 20.246
Nazione #
US - Stati Uniti d'America 8.184
RU - Federazione Russa 2.639
SG - Singapore 1.770
CN - Cina 1.286
GB - Regno Unito 1.113
IT - Italia 573
DE - Germania 509
BR - Brasile 493
VN - Vietnam 439
SE - Svezia 353
HK - Hong Kong 341
FR - Francia 303
IE - Irlanda 259
FI - Finlandia 253
KR - Corea 135
BD - Bangladesh 114
CA - Canada 107
JP - Giappone 102
IN - India 84
UA - Ucraina 73
AR - Argentina 69
NL - Olanda 54
BE - Belgio 45
TR - Turchia 40
ID - Indonesia 39
MX - Messico 37
ZA - Sudafrica 37
PL - Polonia 34
ES - Italia 33
IQ - Iraq 33
NG - Nigeria 33
LT - Lituania 19
PK - Pakistan 18
CL - Cile 17
CO - Colombia 17
VE - Venezuela 17
AT - Austria 15
RO - Romania 14
AU - Australia 12
CH - Svizzera 12
IL - Israele 12
SA - Arabia Saudita 12
EC - Ecuador 11
EG - Egitto 11
JM - Giamaica 11
KE - Kenya 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 9
MA - Marocco 9
NP - Nepal 9
PH - Filippine 9
CZ - Repubblica Ceca 8
HR - Croazia 8
IR - Iran 8
MY - Malesia 8
DZ - Algeria 7
GR - Grecia 7
LB - Libano 7
TG - Togo 7
TN - Tunisia 7
UY - Uruguay 7
BJ - Benin 6
DK - Danimarca 6
HN - Honduras 6
PT - Portogallo 6
BG - Bulgaria 5
BO - Bolivia 5
LV - Lettonia 5
PE - Perù 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BH - Bahrain 4
CR - Costa Rica 4
EE - Estonia 4
ET - Etiopia 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NI - Nicaragua 4
RS - Serbia 4
AM - Armenia 3
GT - Guatemala 3
HU - Ungheria 3
MD - Moldavia 3
NO - Norvegia 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
LK - Sri Lanka 2
OM - Oman 2
PY - Paraguay 2
SI - Slovenia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
Totale 20.051
Città #
Ashburn 1.017
Singapore 998
Moscow 911
Southend 856
Dallas 846
San Jose 752
Chandler 732
Jacksonville 510
Ann Arbor 359
Hong Kong 333
Woodbridge 307
Council Bluffs 272
Dublin 260
Verona 259
Houston 224
Beijing 221
New York 215
The Dalles 195
Ho Chi Minh City 144
Los Angeles 129
Wilmington 119
Munich 114
Princeton 102
Lawrence 101
Tokyo 96
Santa Clara 89
Jinan 85
Hanoi 82
Boardman 78
Nanjing 77
Helsinki 72
Shenyang 70
São Paulo 59
Buffalo 57
Redondo Beach 49
Brussels 45
Columbus 43
Hebei 42
Milan 42
Montreal 40
Tianjin 38
Orem 37
Turku 35
Redmond 34
Lancaster 33
London 33
Sindelfingen 33
Zhengzhou 32
Abuja 31
Changsha 31
Seattle 30
Chicago 29
Haikou 29
Nanchang 29
Brooklyn 28
Johannesburg 28
Toronto 27
Denver 26
Phoenix 26
Rio de Janeiro 26
Jiaxing 25
Warsaw 25
Guangzhou 24
Hangzhou 23
Chennai 21
Falkenstein 21
Frankfurt am Main 21
Jakarta 21
Seoul 21
Amsterdam 20
Atlanta 20
Dong Ket 20
Haiphong 20
Las Vegas 20
Taiyuan 20
Padova 19
Ningbo 18
Taizhou 17
Da Nang 16
Manchester 16
Poplar 16
Falls Church 15
Norwalk 15
Rome 15
Shanghai 15
Stockholm 15
Washington 15
Hải Dương 14
Nürnberg 14
San Francisco 14
Fuzhou 13
Mexico City 13
Mumbai 13
Vienna 13
Ankara 12
Barnet 12
Fairfield 12
McKinney 12
Zurich 12
Baghdad 11
Totale 12.296
Nome #
Epigenetic Regulation Through Histone Deacetylation: Implications and Therapeutic Potential in Hepatocellular Carcinoma 351
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 326
Apolipoprotein -CIII glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 259
ApoCIII glycoforms determination and proteomic analysis in plasma of coronary patients with different ApoCIII levels . 240
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 236
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 235
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 228
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 225
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 220
Hepcidin and DNA promoter methylation in hepatocellular carcinoma 216
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 215
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 214
Identification of new BMP6 pro-peptide mutations in patients with iron overload 213
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 212
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 207
miRNAs purification and analysis from urinary exosomes. 207
Isoelectric beads for proteome pre-fractionation.II :experimental evaluation in a multicompartment electroyzer 205
The proteome: anno Domini 2002 205
Immunoaffinity reactors for prion protein qualitative analysis 204
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 203
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 202
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 200
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 200
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 199
Apolipoprotein C-III glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 198
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 197
Altered paraoxonase expression in patients with genetic haemochromatosis. 195
"Exploring the hidden human urinary proteome via ligand library beads" 194
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 192
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 190
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 187
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 186
Plasma proteomic analysis of patients with Coronary Artery Disease with different levels of apolipoprotein CIII 186
A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. 185
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 184
“Proteomics approaches for studying chemoresistance in cancer” 183
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 183
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 180
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 179
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 179
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 177
Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome 177
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 175
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 175
Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism 174
Iron metabolism in Murine Macrophages: a proteomic insight. 174
Monocyte/macrophage proteomics: recent findings and biomedical applications. 174
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 173
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 172
Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25 172
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 172
How to bring the "unseen" proteome to the limelight via electrophoretic pre-fractionation techniques 172
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 172
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 171
Amphoteric,buffering chromatographic beads for proteome prefractionation.I :theoretical model 170
Prefractionation techniques in proteome analysis: the mining tools of the third millennium. 170
"Prefractionation of urinary proteins" 170
Murine macrophages response to iron 169
Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study 169
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 169
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 167
Serum Uric Acid Levels, but Not rs7442295 Polymorphism of SCL2A9 Gene, Predict Mortality in Clinically Stable Coronary Artery Disease 165
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease 162
Modern iron replacement therapy: clinical and pathophysiological insights 161
The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease 160
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 158
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 158
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 155
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 155
Optimizing the purification and analysis of miRNAs from urinary exosomes. 151
Imprinted polymers for the recognition/quantitation of the peptide hormone hepcidin 150
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 150
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 149
Myristic acid induces proteomic and secretomic changes associated with steatosis, cytoskeleton remodeling, endoplasmic reticulum stress, protein turnover and exosome release in HepG2 cells 149
Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations 147
Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation 147
Reduced serum hepcidin levels in patients with chronic hepatitis C 144
Plasma Proteome Profiles of Stable CAD Patients Stratified According to Total Apo C-III Levels 144
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 142
High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin 141
Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study 140
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 140
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 140
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach 139
Carbamylation of proteins in 2-D electrophoresis--myth or reality? 139
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 139
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 137
Myristic acid plasma levels are strongly correlated with triglyceride and Apolipoprotein C-III plasma concentration in a cohort of subjects with or without coronary artery disease 132
Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material 132
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 130
Hormone-Dependent Changes in Female Urinary Proteome 130
Beta-elimination: an unexpected artefact in proteome analysis. 129
null 129
Circadian exosomal expression of renal thiazide-sensitive NaCl cotransporter (NCC) and prostasin in healthy individuals 126
Hepcidin resistance in dysmetabolic iron overload 124
Urinary extracellular vesicle mRNA analysis of sodium chloride cotransporter in hypertensive patients under different conditions 123
Reducing protein concentration range of biological samples using solid-phase ligand libraries 122
Changes of gene expression in peripheral blood mononuclear cells of lung cancer patients with or without anorexia 121
Treatment options for anemia in the elderly 121
Extracellular Vesicles in Asthma: Intercellular Cross-Talk in TH2 Inflammation 120
Totale 17.535
Categoria #
all - tutte 68.809
article - articoli 53.839
book - libri 0
conference - conferenze 13.273
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.697
Totale 137.618


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022481 0 0 0 63 25 25 7 37 40 18 75 191
2022/20232.004 118 228 166 329 199 468 31 126 257 12 36 34
2023/20241.067 42 88 71 105 116 208 20 68 12 29 188 120
2024/20252.459 122 182 119 420 96 93 125 84 335 158 203 522
2025/20269.011 554 405 879 1.507 2.260 569 847 438 624 523 142 263
2026/20271.137 125 224 284 504 0 0 0 0 0 0 0 0
Totale 20.246